- Home
- LAB vs GEVO Comparison
LAB vs GEVO Comparison
Compare LAB & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- GEVO
- Stock Information
- Founded
- LAB 1999
- GEVO 2005
- Country
- LAB United States
- GEVO United States
- Employees
- LAB N/A
- GEVO N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- GEVO Major Chemicals
- Sector
- LAB Industrials
- GEVO Industrials
- Exchange
- LAB Nasdaq
- GEVO Nasdaq
- Market Cap
- LAB 473.2M
- GEVO 418.4M
- IPO Year
- LAB 2011
- GEVO 2011
- Fundamental
- Price
- LAB $1.30
- GEVO $1.67
- Analyst Decision
- LAB Buy
- GEVO Buy
- Analyst Count
- LAB 2
- GEVO 2
- Target Price
- LAB $2.50
- GEVO $7.58
- AVG Volume (30 Days)
- LAB 1.2M
- GEVO 9.5M
- Earning Date
- LAB 10-29-2025
- GEVO 08-11-2025
- Dividend Yield
- LAB N/A
- GEVO N/A
- EPS Growth
- LAB N/A
- GEVO N/A
- EPS
- LAB N/A
- GEVO N/A
- Revenue
- LAB $172,271,000.00
- GEVO $80,187,000.00
- Revenue This Year
- LAB N/A
- GEVO $909.99
- Revenue Next Year
- LAB N/A
- GEVO $22.37
- P/E Ratio
- LAB N/A
- GEVO N/A
- Revenue Growth
- LAB 76.33
- GEVO 341.75
- 52 Week Low
- LAB $0.92
- GEVO $0.67
- 52 Week High
- LAB $2.32
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- LAB 53.08
- GEVO 53.71
- Support Level
- LAB $1.20
- GEVO $1.54
- Resistance Level
- LAB $1.31
- GEVO $1.80
- Average True Range (ATR)
- LAB 0.07
- GEVO 0.10
- MACD
- LAB 0.00
- GEVO -0.02
- Stochastic Oscillator
- LAB 68.75
- GEVO 40.62
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.